Anthem Biosciences Limited has made an initial public offering of equity shares aggregating to ₹3,395 crore. Trilegal ...

The Bengaluru-based contract research, development, and manufacturing organisation (CRDMO) saw overwhelming investor demand, with the Rs 3,395-crore IPO getting subscribed 67.42 times overall.

AM, Anthem Biosciences share price on the BSE was trading at Rs. 730.70, up Rs. 7.60 or 1.05% from the listing price and a 28.19% gain over the issue price. On the NSE, the stock was quoted at Rs. 730 ...

Anthem Biosciences Ltd ended its debut trading day with a premium of over 28%. Despite the high opening figures, the company ...

Anthem Biosciences IPO listing date is today. Ahead of the listing, Anthem Biosciences IPO GMP today and analysts signal a ...

True North and Faering-backed Anthem Biosciences surges ~28% on NSE/BSE debut, reflecting strong IPO sentiment and investor ...

Its shares were listed at Rs 723 apiece on the BSE, a premium of 26.85 per cent as against the IPO issue price of Rs 570.

Anthem Biosciences, a leading contract research and manufacturing organization (CRDMO), made a strong debut on the Indian ...

Key Details and Listing Information<br />The bidding for the Anthem Biosciences Initial Public Offering (IPO) took place from July 14 to July 16, 2025. The company finalized its share allotment on ...

Shares of Anthem Biosciences Ltd listed with a premium of nearly 27% against the issue price of ₹570 on Monday ...

Anthem Biosciences Ltd listed on BSE and NSE at a premium of around 27 per cent on each. Zee Business managing editor, Anil ...

Anthem Biosciences made a strong debut on the stock exchanges on Monday, listing at nearly 27 per cent premium over its ...